Emerging Technologies

IBM supercomputer and Amazon join Joe Biden’s fight against cancer

Joe Biden talks with Elizabeth Blackburn, President of The Salk Institute for Biological Studies during the session "Cancer Moonshot: A Call to Action" during the annual meeting of the World Economic Forum (WEF) in Davos, Switzerland January 19, 2016. REUTERS/Ruben Sprich - RTX232U2

Joe Biden with Nobel laureate Elizabeth Blackburn at Davos in 2016 Image: REUTERS/Ruben Sprich

Ceri Parker
Previously Commissioning Editor, Agenda, World Economic Forum

Silicon Valley has stepped into the fight against cancer as part of former US Vice President Joe Biden’s “moonshot” initiative to put an end to the disease as we know it.

Loading...

In an update delivered on the eve of Davos 2017, Biden explained how a combination of better collaboration and promising new techniques meant we were at an “inflexion point” in the fight against cancer.

“We got a call from IBM: How would you like to borrow Watson?” Biden said, referring to the supercomputer which uses machine learning to improve its responses to questions.

Famous for trouncing human contestants in the quiz game Jeopardy! In 2011, Watson is now serving a more serious purpose: searching for the best therapies for cancer patients based on their genome sequences, in a collaboration with the Walter Reed military hospital.

Loading...

This is just one example of what Biden calls a “culture change” to tear through silos in the fight against a disease which kills 16 million people a year around the world.

“Amazon came along and said look, we’ll add cloud computing,” continued Biden. He said the company stored enormous amounts of cancer data, with open access making it available to any scientist in the world.

In a similar vein, a group of young tech specialists from Silicon Valley built a web platform, trials.cancer.gov, to allow people with cancer to register for clinical trials. Currently, only 5% of cancer patients have access to trials, which in some cases represent their last hope of finding a treatment. At the same time, pharmaceutical companies struggle to find participants.

With a new president now in office, Biden said that he had already informed Vice President Mike Pence of his willingness to continue to work with him and the incoming administration. Biden, who lost his son to cancer, said he would also launch his own initiative to continue the work of the Moonshot programme.

Have you read?

For more, watch a special address by Joe Biden here.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Health and Healthcare

Related topics:
Emerging TechnologiesFourth Industrial RevolutionHealth and Healthcare Systems
Share:
The Big Picture
Explore and monitor how Artificial Intelligence is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

5 ways to achieve effective cyber resilience

Filipe Beato and Jamie Saunders

November 21, 2024

Why AI is Southeast Asia's new engine for profitable growth

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum